ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Alpha Cognition Inc

Alpha Cognition Inc (ACOG)

0,24
0,00
( 0,00% )
Aktualisiert: 01:00:00

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
0,24
Gebot
0,23
Fragen
0,30
Volumen
-
0,00 Tagesbereich 0,00
0,24 52-Wochen-Bereich 0,24
Marktkapitalisierung
Handelsende
0,24
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
-
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
-
Ausgegebene Aktien
118.208.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,86
Gewinn pro Aktie (EPS)
-0,12
Erlöse
-
Nettogewinn
-13,77M

Über Alpha Cognition Inc

Sektor
Pharmaceutical Preparations
Branche
Finance Services
Hauptsitz
Vancouver, British Columbia, Can
Gegründet
2021
Alpha Cognition Inc is listed in the Pharmaceutical Preparations sector of the TSX Venture Börse with ticker ACOG. The last closing price for Alpha Cognition was $0,24. Over the last year, Alpha Cognition shares have traded in a share price range of $ 0,24 to $ 0,24.

Alpha Cognition currently has 118.208.000 shares in issue. The market capitalisation of Alpha Cognition is $28,37 million. Alpha Cognition has a price to earnings ratio (PE ratio) of -0.86.

ACOG Neueste Nachrichten

Alpha Cognition Announces Financial Results for the Second Quarter and Six Months Ended June 2024 and Provides Corporate Update

Alpha Cognition Inc. (OTCQB: ACOG) (CSE: ACOG) (“Alpha Cognition,” or the “Company”), a biopharmaceutical company developing novel therapeutics for debilitating neurodegenerative disorders, today...

Alpha Cognition Announces Fourth Quarter and Full Year 2022 Results and Provides Corporate Update

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the...

Alpha Cognition Provides Private Placement Update

Not for distribution in the United States or to U.S. newswire services Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company...

Alpha Cognition Announces Third Quarter 2022 Results and Provides Corporate Update

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the...

Alpha Cognition Announces Withdrawal of Marketed Public Offering

NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VANCOUVER, British Columbia, Nov. 28, 2022 (GLOBE NEWSWIRE) -- Alpha Cognition Inc. (“Alpha” or the “Company”...

Alpha Cognition Announces Marketed Offering

NOT FOR DISSEMINATION IN THE UNITED STATESOR THROUGH U.S. NEWSWIRE SERVICES VANCOUVER, British Columbia, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Alpha Cognition Inc. (“Alpha” or the “Company”...

Alpha Cognition Announces Second Quarter 2022 Results and Provides Corporate Update

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies with the potential to transform the...

Alpha Cognition Announces Positive Topline Results from Bioequivalence Study with ALPHA-1062 in Development for Alzheimer’s Disease

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition,” or the “Company”), a biopharmaceutical company committed to developing novel therapies for people with debilitating...

Life Sciences Investor Forum Presentations Now Available for On-Demand Viewing

NEW YORK, June 24, 2022 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced that the presentations from the June 23rd Life...

Alpha Cognition Announces Positive Results from Pivotal Study with ALPHA-1062 in Development for Alzheimer’s Disease

Alpha Cognition Inc. (TSX-V: ACOG) (OTCQB: ACOGF) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies for people with debilitating...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1000.240.240.2400CS
4000.240.240.2400CS
12000.240.240.2400CS
26000.240.240.2400CS
52000.240.240.2400CS
156-0.91-79.13043478261.151.350.2183460.70568887CS
260-1.13-82.48175182481.372.490.21112680.9397552CS
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ETUE2gold Inc
$ 0,01
(100,00%)
5k
MVYMoovly Media Inc
$ 0,01
(100,00%)
10k
WAVEWaverley Pharma Inc
$ 0,015
(50,00%)
1.000
NXSNexus Gold Corp
$ 0,015
(50,00%)
1,5k
RECRecord Resources Inc
$ 0,035
(40,00%)
102k
PDVN.PPardus Ventures Inc
$ 0,005
(-75,00%)
5k
TVITVI Pacific Inc
$ 0,005
(-50,00%)
50k
MINKMink Ventures Corporation
$ 0,05
(-37,50%)
102k
GBUGabriel Resources Ltd
$ 0,01
(-33,33%)
16,94k
CLMConsolidated Lithium Metals Inc
$ 0,01
(-33,33%)
1M
PERUChakana Copper Corp
$ 0,03
(20,00%)
1,96M
CLMConsolidated Lithium Metals Inc
$ 0,01
(-33,33%)
1M
MCFMCF Energy Ltd
$ 0,075
(0,00%)
990,45k
ACUAurora Solar Technologies Inc
$ 0,025
(0,00%)
951,65k
ULTUltra Lithium Inc
$ 0,01
(-33,33%)
850,49k
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock